SCHEMBL2648811

SCHEMBL2648811

CN(C)C(=O)CN1CCCN(c2cccc(N)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 1/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TSHR P16473 1/20 0.46
PIK3CD O00329 1/20 0.45
HRH3 Q9Y5N1 1/20 0.42
ALDH1A1 P00352 5/20 0.42
MAPT P10636 3/20 0.42
ATM Q13315 1/20 0.42
OPRK1 P41145 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
GFER P55789 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2661783 0.82 ALDH1A1 (0.55) ADRA2CMEN1KMT2ATSHRALDH1A1
SCHEMBL1813872 0.80 MAPT (0.57) ADRA2CMEN1KMT2AALDH1A1MAPT
SCHEMBL2661540 0.78 ADRA2C (0.54) ADRA2CMEN1KMT2ATSHRALDH1A1
SCHEMBL2658926 0.78 ADRA2C (0.54) ADRA2CMEN1KMT2ATSHRALDH1A1
SCHEMBL2659291 0.78 GAA (0.58) ADRA2CMAPTGFERSMN1; SMN2
SCHEMBL2661949 0.77 ADRA2C (0.50) ADRA2CMEN1KMT2ATSHRALDH1A1
SCHEMBL27808023 0.77 ADRA2C (0.60) ADRA2CMEN1KMT2ATSHRALDH1A1
SCHEMBL2648606 0.76 ADRA2C (0.53) ADRA2CMEN1KMT2ATSHRALDH1A1
SCHEMBL17976220 0.76 OPRK1 (0.49) HRH3OPRK1GFER
SCHEMBL17976036 0.75 OPRK1 (0.48) HRH3ALDH1A1OPRK1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002050057-A1 NOVEL BENZIMIDAZOLE DERIVATIVES FOR THE TREATMENT OF GABA-ALPHA MEDIATED DISORDERS NEUROSEARCH A/S (DK) 2002-06-27 WO disclosed